Mirum Pharmaceuticals, Inc. , a leading rare disease company, today announced that Health Canada has authorized the tablet formulation of LIVMARLI® (maralixibat) for the treatment of cholestatic ...

As the management landscape of primary biliary cholangitis (PBC) changes, new second-line options offer effective ...

Less than a month after taking steps to permanently ban the trade and consumption of live wild animals for food, the Chinese government has recommended using Tan Re Qing, an injection containing bear ...

Dicamba, a drift-prone herbicide, is slated to be reapproved by EPA in the coming days, despite a long history of adverse ...